Search
Consumer_Obesity_Findings_MAR_24.pdf
-
Ipsos launches GLP-1 PersonaBot, designed to support companies’ understanding of the consumer obesity treatment market
Ipsos’ latest AI-powered innovation offers unparalleled insights into the fast-moving consumer obesity treatment market – while reinforcing Ipsos’ position at the forefront of AI applications in market research.
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
Our evolutionary tale began 6 million years ago, when humans were programmed to hoard calories in a world of scarcity. Today, that ancient wiring has become our greatest health risk.
-
Ipsos Update – December 2024
Security, Inflation, Perils of Perception … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
GLP–1s: A Healthcare Revolution?
One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.
-
Ipsos Health Service Report 2024: Mental Health seen as the biggest Health issue
Across 31 countries 44% rate the quality of the healthcare they receive as good, but access to treatment and not enough staff are seen as major systemic challenges
-
Mental health is now the number one health problem, ahead of cancer and coronavirus
48% across 31 countries say the quality of the healthcare in their country is good – but the picture is inconsistent.
-
Mental health concern rises in the age of COVID-19
Younger people are struggling the most with stress and emotional wellness, but they don’t see those struggles as ‘taboo’ and are openly talking about their challenges more than older generations.